Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients

Gachon University Gil Medical Center

Status and phase: Completed; Phase 4

Conditions: Hypertriglyceridemia

Treatments: Drug: fenofibrate

Study type: Interventional

Funder types: Other

Identifiers

NCT00745407

GMC 200511

Details and patient eligibility

About

Fenofibrate increases adiponectin levels, but reduces leptin levels

Sex: All

Ages: 25 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• hypertriglyceridemia

Exclusion criteria

• chronic liver disease

Trial design

0 participants in 1 patient group

fenofibrate 160 mg, placebo

Experimental group

Treatment:

Drug: fenofibrate